Paroxetine Tablet, Film Coated
Product Images NDC 62135-541

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 62135-541). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Paroxetine Fig 1)

Image Description (Paroxetine Fig 1)
A pharmacokinetic fold change chart showing the effects of various interacting drugs (Pimozide, Desipramine, Propranolol, Digoxin, Phenytoin) on Cmax and AUC relative to a reference. The horizontal log-scale axis ranges from 0.1 to 10, displaying fold changes and 90% confidence intervals for these parameters.*
FDA Label Image

Image Description (Paroxetine Fig 2)

Image Description (Paroxetine Fig 2)
A chart depicting fold change and 90% confidence intervals of pharmacokinetic parameters Cmax and AUC for Paroxetine when co-administered with various interacting drugs, including Cimetidine 300 mg three times daily, Phenobarbital 100 mg once daily, Phenytoin 300 mg once daily, Digoxin 0.25 mg once daily, and Diazepam 5 mg three times daily. The x-axis represents change relative to reference.*
FDA Label Image

Image Description (Paroxetine Fig 3)

Image Description (Paroxetine Fig 3)
A pharmacokinetic chart showing fold changes and 90% confidence intervals for PAROXETINE in different populations. It compares Cmax, AUC, and Cmin values for mild, moderate, and severe renal impairment, hepatic impairment, age groups over 65 with different doses, and males, relative to a reference.*
FDA Label Image

Image Description (Paroxetine Structure)

Image Description (Paroxetine Structure)
Chemical structure of paroxetine hydrochloride, the active ingredient in PAROXETINE tablets. The diagram shows the molecular arrangement including the fluorophenyl group, the piperidine ring, and the hydrochloride salt form.*
FDA Label Image

Image Description (Peroxetine Tab 10mg)

Image Description (Peroxetine Tab 10mg)
Paroxetine 10 mg film-coated tablets packaging label for 90 tablets from Chartwell Rx, LLC. The label includes drug name, strength, quantity, and storage instructions. It specifies prescription-only status and provides a website for medication guides. No varnish is applied to the label.*
FDA Label Image

Image Description (Peroxetine Tab 20mg)

Image Description (Peroxetine Tab 20mg)
Paroxetine Tablets, USP 20 mg film-coated tablets label from Chartwell Rx, LLC. The container holds 90 tablets with the NDC 62135-542-90. The label includes storage instructions, dispensing and dosage notes, manufacturer details, and a barcode. It clearly states 'Rx Only' and features the phrase 'No Varnish' on one side.*
FDA Label Image

Image Description (Peroxetine Tab 30mg)

Image Description (Peroxetine Tab 30mg)
Paroxetine 30 mg tablets, USP label for oral film-coated tablets by Chartwell RX, LLC. The label indicates 90 tablets per container with prescription only status. It includes storage instructions, manufacturer details, barcode, and safety warnings with no varnish on the label.*
FDA Label Image

Image Description (Peroxetine Tab 40mg)

Image Description (Peroxetine Tab 40mg)
Label for Paroxetine tablets, USP 40 mg by Chartwell Rx, LLC. The label states prescription only, contains 90 film-coated tablets, and includes storage instructions, manufacturer details, and a barcode. The label prominently features the strength as 40 mg with no varnish finish.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.